Reference health
Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study
34/34 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 34 checked references that resolve
resolves10.1080/01688639408402681
Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine-blood-level
resolves10.1016/S0028-3932(01)00078-1
Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations
resolves10.1016/j.ymgme.2009.10.007
Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆
resolves10.1016/j.ymgme.2012.11.003
A diversified approach for PKU treatment: Routine screening yields high incidence of psychiatric distress in phenylketonuria clinics
resolves10.1007/s10545-008-0918-6
The truth of treating patients with phenylketonuria after childhood: The need for a new guideline
resolves10.1038/gim.2013.157
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
resolves10.1016/S0140-6736(02)09334-0
How practical are recommendations for dietary control in phenylketonuria?
resolves10.1007/s10545-005-0014-0
Behavioural factors related to metabolic control in patients with phenylketonuria
resolves10.1023/B:BOLI.0000028781.94251.1f
Executive function impairment in early‐treated PKU subjects with normal mental development
resolves10.1055/s-2008-1071561
Neuroradiological (MRI) Abnormalities in Phenylketonuric Subjects: Clinical and Biochemical Correlations
resolves10.1080/87565640802101482
Twenty-Five Years of Research on Neurocognitive Outcomes in Early-Treated Phenylketonuria: Intelligence and Executive Function
resolves10.1023/A:1005587915468
Regression of neuropsychological deficits in early‐treated phenylketonurics during adolescence
resolves10.1076/jcen.25.2.242.13639
Normative Data From the Cantab. I: Development of Executive Function Over the Lifespan
resolves10.1111/j.1469-7610.2006.01611.x
Development of the adolescent brain: implications for executive function and social cognition
resolves10.1523/JNEUROSCI.2345-13.2013
Functional Maturation of the Executive System during Adolescence
resolves10.1016/j.ymgme.2013.08.013
Neurocognitive functioning in adults with phenylketonuria: Results of a long term study
resolves10.1016/j.neubiorev.2008.11.001
Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis
resolves10.1016/j.ymgme.2009.10.009
Beyond executive function: Non-executive cognitive abilities in individuals with PKU☆
resolves10.1006/cogp.1999.0734
The Unity and Diversity of Executive Functions and Their Contributions to Complex “Frontal Lobe” Tasks: A Latent Variable Analysis
resolves10.1016/0168-5597(91)90036-W
The development of auditory and visual evoked potentials in early treated phenylketonuric children
resolves10.1093/brain/116.4.811
Brain MRI changes in phenylketonuria: Associations with dietary status
resolves10.1016/S0022-3476(95)70303-9
Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change
resolves10.1016/j.ymgme.2013.07.010
White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria
resolves10.1016/j.ymgme.2013.03.020
White matter integrity and executive abilities in individuals with phenylketonuria
resolves10.1007/BF01957228
White matter abnormalities in patients with treated hyperphenylalaninaemia: Magnetic resonance relaxometry and proton spectroscopy findings
resolves10.1203/00006450-200104000-00015
Normal Clinical Outcome in Untreated Subjects with Mild Hyperphenylalaninemia
resolves10.1148/radiol.2362040611
Diffusion-weighted MR Imaging in Patients with Phenylketonuria: Relationship between Serum Phenylalanine Levels and ADC Values in Cerebral White Matter
resolves10.1007/s00234-009-0574-z
Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria
resolves10.1016/j.ymgme.2014.01.012
Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria
resolves10.1016/j.ymgme.2014.11.007
Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria
The 2 references without a DOI — listed, not checked
no DOI — not checkedAlternative therapies to address the unmet medical needs of patients with phenylketonuria
no DOI — not checkedBrain mechanisms in problem solving and intelligence: g and executive function
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.ymgme.2015.04.003"><img src="https://citestamp.com/citestamped/10.1016/j.ymgme.2015.04.003/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.ymgme.2015.04.003)